Portfolio

TiGenix has obtained a licence for commercial production at its Spanish facility

By 07/09/2017June 4th, 2021No Comments

TiGenix has obtained a licence for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid, Spain, following an inspection by the Spanish Medicines Agency (AEMPS).